This subproject will evaluate the health impacts of transport related emissions. It will be based on both existing studies and on the recently funded European Study of Cohorts for Air Pollution Effects (ESCAPE). This SP will develop source specific concentration response functions suitable for application in health impact assessments
The ESCAPE study includes 33 cohorts, subdivided in four major groups:
1. Birth cohorts on pregnancy outcomes, allergy and asthma, and neuro developmental effects
2. Cohorts on adult respiratory disease outcomes
3. Cohorts on adult cardiovascular disease outcomes
4. ohorts on cancer incidence and mortality outcomes.
The collaboration in ESCAPE represents a large investment in ongoing cohort studies in Europe, from a wide range of local, national and international funds. ESCAPE adds assessment of air pollution exposure to these studies, with an emphasis on spatial contrasts in PM and NOx from road transport. Measurements of PM2.5, PM10 and NOx are being conducted 22 different areas; measurements of NOx only are being conducted in an additional 17 areas. PM measurements are being conducted on 20 different sites in each area to investigate spatial contrasts while NOx is measured at 40 sites per area.
With the new information generated in TRANSPHORM and ESCAPE on exposure response functions, for long and short term effects, the impacts of transport related PM pollution on health can be assessed. It should be noted that the effects of long-term exposure (for which we will have new C-R functions) are by far the dominant ones in terms of public health overall. However, TRANSPHORM will also develop new functions for acute exposures providing a unique comprehensive treatment of short and long term effects resulting from PM air pollution.
Contact: Bert Brunekreef
(SP leader), Dimosthenis Sarigiannis
(SP deputy leader)